Please login to the form below

Not currently logged in
Email:
Password:

ATMPs

This page shows the latest ATMPs news and features for those working in and with pharma, biotech and healthcare.

Europe urged to adapt faster to gene therapy challenges

Europe urged to adapt faster to gene therapy challenges

ATMP-dedicated funds, allowing health systems to invest in ATMPs that offer the potential for long-term benefits. ... Expansion of opportunities for early dialogue between ATMP developers and payers, supported by increased EU funding.

Latest news

More from news
Approximately 3 fully matching, plus 15 partially matching documents found.

Latest Intelligence

  • The European Medicines Agency: PRIME’d for access? The European Medicines Agency: PRIME’d for access?

    177 requests for eligibility, or 8 a month on average. 71 requests have been chemical products, 43 biological, 42 ATMPs with the last 13 classed as ‘other’.

  • Europe vs the US: New drug product approvals Europe vs the US: New drug product approvals

    Two Advanced Therapy Medicinal Products (ATMP), Strimvelis (for the treatment of severe combined immunodeficiency) and Zalmoxis (for the treatment of certain types of high-risk haematological malignancies), were approved in the

  • Gathering pace: adaptive pathways Gathering pace: adaptive pathways

    Applications included six advanced-therapy medicinal products (ATMPs) and 12 orphan drugs, while 14 of them were for new cancer therapies. ... The first of these in-depth discussions, on the quality aspects of an ATMP, took place in December 2014, with

More from intelligence
Approximately 0 fully matching, plus 3 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 2 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Bedrock Group

Bedrock Healthcare Communications is a privately owned, award winning communications agency that creates and delivers highly effective, insight driven medical...

Latest intelligence

RWE Blog 3: Is real-world evidence the holy grail
We began our four-blog series by evaluating the role of real-world data (RWD) and real-world-evidence (RWE) in Real-world challenges and real-world data, and understanding the payer's perspective, in Payers use...
What do Healthcare Professionals think about the inclusion of remote selling techniques?
Evolving to a digitally focused pharma / healthcare company - an organisational roadmap...
Drug pricing and competition
Strengthening business competition and reducing anti-competitive practices
How the CMA is tackling high prices for essential drugs...

Infographics